WEKO3
アイテム
How Can Antimicrobial Resistance in Pseudomonas aeruginosa Be Controlled?
https://repository.lib.tottori-u.ac.jp/records/5051
https://repository.lib.tottori-u.ac.jp/records/505187a0d4ea-334d-4a48-91d4-162a4582c333
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
50_001-008.pdf (141.9 kB)
|
|
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2018-06-22 | |||||
| タイトル | ||||||
| タイトル | How Can Antimicrobial Resistance in Pseudomonas aeruginosa Be Controlled? | |||||
| 言語 | en | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| キーワード | ||||||
| 主題 | antimicrobial resistance | |||||
| キーワード | ||||||
| 主題 | antimicrobial therapy | |||||
| キーワード | ||||||
| 主題 | infection control | |||||
| キーワード | ||||||
| 主題 | nosocomial infection | |||||
| キーワード | ||||||
| 主題 | Pseudomonas aeruginosa | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題 | antimicrobial resistance | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題 | antimicrobial therapy | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題 | infection control | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題 | nosocomial infection | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題 | Pseudomonas aeruginosa | |||||
| 資源タイプ | ||||||
| 資源タイプ | journal article | |||||
| 著者 |
Horii, Toshinobu
× Horii, Toshinobu× Horii, Toshinobu |
|||||
| 著者所属 | ||||||
| 値 | Division of Bacteriology, Department of Microbiology and Immunology, School of Medicine, Tottori University Faculty of Medicine and Infection Control Division, Tottori University Hospital | |||||
| 抄録 | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | Pseudomonas aeruginosa remains one of the most difficult to treat and to control nosocomial infections. In vitro antimicrobial susceptibility data are required for successful therapy because acquired resistance to such antimicrobials as β-lactams, fluoroquinolones and aminoglycosides is so prevalent in P. aeruginosa. Strategies for controlling P. aeruginosa infections include early detection of P. aeruginosa as the causative pathogen, determination of its antimicrobial susceptibilities, initiation of effective and adequate therapy and strict infection control practice such as hand hygiene and equipment procedures. Once antimicrobial therapy has been initiated against a P. aeruginosa infection, its susceptibility to antimicrobials, especially to carbapenems and fluoroquinolones, should be monitored during antimicrobial therapy to detect clonal shifts in resistance and microbial substitutions as early as possible. Continued surveillance of nosocomial infections and monitoring of antimicrobial resistance by the infection control staff plays major roles in preventing nosocomial infections and the spread of antimicrobial resistance. Additional strategies for controlling antimicrobial resistance in P. aeruginosa include the development of new methods for rapid detection of antimicrobial resistance and new agents and vaccines against P. aeruginosa infections in the laboratories and pharmaceuticals, while preserving the efficacy of currently available antimicrobials for as long as possible in the hospital settings. | |||||
| 書誌情報 |
Yonago Acta medica en : Yonago Acta medica 巻 50, 号 1, p. 1-8, 発行日 2007-03 |
|||||
| 出版者 | ||||||
| 出版者 | Tottori University Faculty of Medicine | |||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 13468049 | |||||
| 書誌レコードID | ||||||
| 収録物識別子タイプ | NCID | |||||
| 収録物識別子 | AA00892882 | |||||
| 権利 | ||||||
| 権利情報 | Yonago Acta medica 編集委員会 | |||||
| 情報源 | ||||||
| 関連名称 | Yonago Acta medica. 2007, 50(1), 1-8 | |||||
| 著者版フラグ | ||||||
| 出版タイプ | VoR | |||||
